Catalyst will moderate two panel discussions exploring various types of disruptive innovation during the DIA’s 2017 Annual Meeting.

On June 20, Catalyst President Nancy Bradish Myers will moderate a panel exploring “Regulatory Frameworks: How Can Regulators Facilitate Disruptive Innovation?” This will be a wide-ranging discussion, across different technologies and innovations, for example gene therapy/regenerative medicine and other cutting edge advanced technologies.

On June 21, she will moderate a panel looking at “CRISPR: Regulatory Challenges in the Gene Editing Revolution.” She will be joined by panelists representing FDA and innovators in the gene editing space.

DIA 2017 will be held June 19-22, 2017 in Chicago.